Clin2
NCT07032649Likely a fitNot yet recruiting

Benzoyl peroxide cream to prevent cold sore outbreaks

HSV

Part of Infections, Skin clinical trials.

This study tests whether a skin cream (benzoyl peroxide) can prevent cold sores caused by the HSV-1 virus. If you get outbreaks often, you might be able to join and help find a new way to stop them.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have had at least 2 cold sore outbreaks in the last year.
  • You can join visits by video call (telehealth) for 6 months.
  • You are not pregnant, breastfeeding, or planning pregnancy during the study.
  • You are not allergic to benzoyl peroxide (a common acne ingredient).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04065971Recruiting· Phase 4
Test drug for frequent cold sores in the mouth

This trial tests whether 2LHERP® can reduce or manage frequent herpes infections around the mouth. It compares the study drug to a placebo (inactive treatment) in people who get many episodes each year.

Beerzel
NCT07341386Recruiting· Phase 4
Preventing herpes outbreaks in autoimmune rheumatic diseases

This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.

São Paulo, São Paulo
NCT04979975Not yet recruiting· Phase 2
Tested repeat injections for frequent genital herpes outbreaks

This Phase 2 study tests whether repeat doses of UB-621 can make frequent genital herpes outbreaks safer and less frequent. It may help people who have HSV-2 and many recurrences each year.

NCT07330440Enrolling by invitation· Phase 1
MRNA vaccine study for preventing genital herpes

This study tests a new mRNA vaccine designed to protect against herpes simplex virus type 2 (HSV-2), the virus that causes genital herpes. It is for healthy adults who have not had a genital herpes outbreak in the last 6 months.

Beijing
NCT06134492Recruiting· Phase 3
Acyclovir for pneumonia patients with HSV-1 on breathing support

This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.

Freiburg im Breisgau, Baden-Wurttemberg
NCT07449156Not yet recruiting· Phase 1/Phase 2
Testing HB0043 for moderate to severe acne

This trial tests a new medicine, HB0043, to see if it helps adults with moderate to severe facial acne. You cannot use other acne treatments during the study.

Jinan, Shandong

Hear when a new HSV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.